Applying Strategies From Libertarian Paternalism to Decision Making for Prostate Specific Antigen (PSA) Screening
Wheeler, David C
Szymanski, Konrad M
Nelson, David E
BMC cancer 2011 April 21; 11: 148
Despite the recent publication of results from two randomized clinical trials, prostate specific antigen (PSA) screening for prostate cancer remains a controversial issue. There is lack of agreement across studies that PSA screening significantly reduces prostate cancer mortality. In spite of these facts, the widespread use of PSA testing in the United States leads to overdetection and overtreatment of clinically indolent prostate cancer, and its associated harms of incontinence and impotence.
Showing items related by title, author, creator and subject.
Screening for Prostate Cancer With the Prostate-Specific Antigen Test: Are Patients Making Informed Decisions? O'Dell, Kristi J.; Volk, Robert J.; Cass, Alvah R.; Spann, Stephen J. (1999-09)
Evaluation of Two Methods to Facilitate Shared Decision Making for Men Considering the Prostate-Specific Antigen Test Frosch, Dominick L.; Kaplan, Robert M.; Felitti, Vincent (2001-06)
Part 2: Patient Information, Informed Decision-Making and the Psycho-Social Impact of Prostate-Specific Antigen Testing Hewitson, Paul; Austoker, Joan (2005-04)